Form 8-K - Current report:
SEC Accession No. 0001585364-24-000147
Filing Date
2024-12-20
Accepted
2024-12-20 08:52:50
Documents
14
Period of Report
2024-12-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K prgo-20241218.htm   iXBRL 8-K 31925
  Complete submission text file 0001585364-24-000147.txt   226923

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20241218.xsd EX-101.SCH 3971
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20241218_def.xml EX-101.DEF 17935
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20241218_lab.xml EX-101.LAB 33694
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20241218_pre.xml EX-101.PRE 18907
17 EXTRACTED XBRL INSTANCE DOCUMENT prgo-20241218_htm.xml XML 7042
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 241565302
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)